ImmunoPrecise Antibodies Ltd. Quarterly Assets in CAD from Q1 2020 to Q3 2024

Taxonomy & unit: ifrs-full: CAD
Summary: ImmunoPrecise Antibodies Ltd. quarterly Assets history and growth rate from Q1 2020 to Q3 2024.
ImmunoPrecise Antibodies Ltd. Assets for the quarter ending October 31, 2024 was CA$60M, a 20.7% decline year-over-year.

Assets, Quarterly (CAD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	60M	-15.6M	-20.7%	Oct 31, 2024	6-K	2024-12-10
Q2 2024	59.3M			Jul 31, 2024	6-K	2024-09-16
Q1 2024	60M	-17.8M	-22.9%	Apr 30, 2024	6-K	2024-12-10
Q4 2023	78.7M			Jan 31, 2024	6-K	2024-03-14
Q3 2023	75.6M			Oct 31, 2023	6-K/A	2024-02-15
Q1 2023	77.8M	-15.8M	-16.9%	Apr 30, 2023	20-F	2024-07-29
Q1 2022	93.6M	+26.7M	+39.9%	Apr 30, 2022	40-F	2023-07-10
Q1 2021	67M	+39.7M	+146%	Apr 30, 2021	40-F	2022-07-29
Q1 2020	27.3M			Apr 30, 2020	40-F/A	2021-09-29

* An asterisk sign (*) next to the value indicates that the value is likely invalid.